Actively Recruiting
Clinic-based Versus Hotspot-focused Active TB Case Finding
Led by Johns Hopkins University · Updated on 2026-03-05
150000
Participants Needed
1
Research Sites
230 weeks
Total Duration
On this page
Sponsors
J
Johns Hopkins University
Lead Sponsor
N
National Heart, Lung, and Blood Institute (NHLBI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This five-year study will evaluate two strategies for conducting tuberculosis (TB) active case finding (ACF) and linkage to TB treatment or TB preventive therapy (TPT) in peri-urban Uganda. The two strategies differ in the location where ACF activities are performed: A "facility-based" ACF/TPT strategy will perform ACF, plus linkage to TPT, in the immediate vicinity of a large public health facility and will primarily recruit individuals who are attending the health facility, irrespective of TB suspicion or symptoms. Alternatively, a "hotspot-based" strategy will use routine notification data and local expertise to identify local TB hotspots - defined as the geographic areas though to have the highest burden of undiagnosed TB per estimated population. The same infrastructure (personnel, equipment, supplies, etc.) for ACF/TPT will then be placed in those zones for a period of four months at a time, and the general population will be recruited for screening and linkage to TPT. The two interventions will be compared in a Type 1 hybrid effectiveness-implementation trial with a cluster-randomized, multiple-period crossover design. The study will evaluate whether hotspot-focused ACF/TPT results in a greater number of TB patients diagnosed and linked to care, and a greater number of individuals started on preventive therapy, than facility-based ACF/TPT. Secondarily, it will also compare the two interventions in terms of number of people initiated on TPT, and it will compare TB cases detected in regions performing ACF/TPT (either approach) against cases detected in regions that continue to perform the standard of care.
CONDITIONS
Official Title
Clinic-based Versus Hotspot-focused Active TB Case Finding
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 15 years or older, OR age 5-14 years and a close contact of someone diagnosed with TB
- Provide oral informed consent, or, if under 18 and not legally emancipated, provide oral informed assent (ages 8-17) plus parental informed consent (ages 5-17)
- Ability to communicate with study staff in English or Luganda, or have an acceptable interpreter available
You will not qualify if you...
- Currently on treatment for active TB
- Diagnosed with active TB but not yet treated
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Walimu
Kampala, Uganda
Actively Recruiting
Research Team
E
Emily A Kendall, MD PhD
CONTACT
D
David W Dowdy, MD PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
SCREENING
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here